Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using Teriflunomide.
Nupur GreeneKeiko HiguchiKatalin BognarEunice ChangMichael S BroderPublished in: ClinicoEconomics and outcomes research : CEOR (2022)
High adherence to teriflunomide was found to be associated with fewer relapses and lower healthcare utilization among patients with RRMS.